E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2022 in the Prospect News Investment Grade Daily.

New Issue: GE HealthCare prices $8.25 billion of senior notes in six tranches

By Wendy Van Sickle

Columbus, Ohio, Nov. 9 – GE Healthcare Holding LLC (GE HealthCare) priced $8.25 billion of senior notes (Baa2//BBB) on Wednesday in six tranches, according to a news release.

The notes include

• $1 billion of 5.55% senior notes due 2024;

• $1.5 billion of 5.6% senior notes due 2025;

• $1.75 billion of 5.65% senior notes due 2027;

• $1.25 billion of 5.857% senior notes due 2030;

• $1.75 billion of 5.905% senior notes due 2032; and

• $1 billion of 6.377% senior notes due 2052.

The notes are being offered as part of the financing for the proposed spinoff of GE HealthCare from General Electric Co., which is expected to be completed in the first week of January 2023.

The notes due 2030, 2032 and 2052 will initially be issued by GE HealthCare to General Electric Co. and are expected to be transferred and delivered by General Electric to BofA Securities, Inc. and Morgan Stanley & Co. LLC, as selling noteholders, in satisfaction of certain debt obligations in connection with the spinoff. GE HealthCare will not receive any proceeds from the offering of these securities.

The closing of the offering is not contingent on the completion of the spinoff. The notes will be guaranteed by General Electric until completion of the spinoff, after which it will be released automatically from all obligations under its guarantees.

GE HealthCare expects to convert into a corporation and be renamed GE HealthCare Technologies Inc. prior to the completion of the spinoff.

Investor calls took place on Tuesday and Wednesday, according to a source.

The source expected that the deal would be split into benchmark tranches denominated in dollars and euros, but the company announced only dollar notes in its release Wednesday evening.

The Rule 144A and Regulation S dollar notes were expected to come across two-year to 30-year tenors.

In addition to BofA Securities and Morgan Stanley, joint bookrunners include BNP Paribas Securities Corp., Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC.

The notes will initially be guaranteed by General Electric Co. After the spinoff, General Electric will no longer be listed on the notes.

The issuer is a global medical technology, pharmaceutical diagnostics and digital solutions provider.

Issuer:GE Healthcare Holding LLC
Guarantor:General Electric Co. (only until spinoff of issuer)
Amount:$8.25 billion
Issue:Senior notes
Bookrunners:BofA Securities, Inc., Morgan Stanley & Co. LLC, BNP Paribas Securities Corp., Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC
Pricing date:Nov. 9
Settlement date:Nov. 22
Ratings:Moody’s: Baa2
Fitch: BBB
Distribution:Rule 144A and Regulation S
2024 notes
Amount:$1 billion
Maturity:2024
Coupon:5.55%
2025 notes
Amount:$1.5 billion
Maturity:2025
Coupon:5.6%
2027 notes
Amount:$1.75 billion
Maturity:2027
Coupon:5.65%
2030 notes
Amount:$1.25 billion
Maturity:2030
Coupon:5.857%
2032 notes
Amount:$1.75 billion
Maturity:2032
Coupon:5.905%
2052 notes
Amount:$1 billion
Maturity:2052
Coupon:6.377%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.